Find clinical trials for Alzheimer's Disease in Aurora, CO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Aurora, CO, USA:
or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's...
Denver, Colorado, United States of America and 69 other locations
This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental declin...
Phase 2
Englewood, Colorado, United States and 38 other locations
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease (SESAD)
FDA-approved for bone marrow stimulation (called sargramostim) will be tested for its safety and efficacy in individuals with mild-to-moderate Alzheimer's...
Phase 2
Aurora, Colorado, United States
and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...
Phase 2
Englewood, Colorado, United States and 96 other locations
Xanamem® is being developed as a potential treatment for symptomatic, early stages of Alzheimer's Disease (AD) and Major Depressive...
Phase 2, Phase 3
Denver, Colorado, United States and 34 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
Denver, Colorado, United States of America and 246 other locations
Randomized efficacy and safety study of piromelatine 20 mg versus placebo in participants with mild dementia due to Alzheimer's disease...
Phase 2, Phase 3
Denver, Colorado, United States and 36 other locations
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.Participants who complete...
Denver, Colorado, United States of America and 53 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Denver, Colorado, United States of America and 200 other locations
to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's...
Phase 2
Aurora, Colorado, United States and 52 other locations
Clinical trials
Research sites
Resources
Legal